Toggle navigation
Home
About
Blog
Contact
Blog
PTAB Affirms Examiner’s Rejection of Claims to Prodrug of Anti-Malarial Drug
Undue experimentation not required to synthesize novel prodrug.
Compound Patents
April 17, 2022
Categories
Hatch Waxman Litigation
Claim Construction
Method of Use Patents
Label Carve-Outs
Biotechnology
Purity Patents
Exception Excipient Rules
Compound Patents
Doctrine of Equivalents
Formulation Patents
Orange Book Issues
Tax
Pharmacokinetic Patents
IP Contracts
Achive
April 2024
March 2024
December 2023
July 2023
April 2022
January 2022
December 2021
March 2021
January 2021
December 2020
October 2020
August 2020
June 2020
May 2020
April 2020
November 2019
October 2019
September 2019
January 2019
November 2018
June 2018
May 2018
April 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
February 2017
January 2017
Subscribe to our blog